| Literature DB >> 9587193 |
T J Wyckoff1, C R Raetz, J E Jackman.
Abstract
Antibiotic-resistant bacterial infections are a major clinical problem. Lipid A, the active part of lipopolysaccharide endotoxins in Gram-negative bacteria, is an intriguing target for new antibacterial and anti-inflammatory agents. Inhibition of lipid A biosynthesis kills most Gram-negative bacteria, increases bacterial permeability to antibiotics and decreases endotoxin production.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9587193 DOI: 10.1016/s0966-842x(98)01230-x
Source DB: PubMed Journal: Trends Microbiol ISSN: 0966-842X Impact factor: 17.079